Multiple reports have shown that PI3K/AKT signaling is required for the expression of the COX-2 gene [9–11], and COX-2 upregulation in response to hepatocyte growth factor (HGF) signaling via this PI3K/AKT pathway has been linked to enhanced invasivity in breast cancer cells [12]. This evidence concerns the gene PTGS2 and breast carcinoma.